CLINICAL TRIALS PROFILE FOR SOTRADECOL
✉ Email this page to a colleague
All Clinical Trials for SOTRADECOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00442364 ↗ | Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt | Completed | Boston Scientific Corporation | Phase 2 | 2007-03-01 | The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart). |
NCT00442364 ↗ | Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt | Completed | BTG International Inc. | Phase 2 | 2007-03-01 | The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart). |
NCT01408732 ↗ | Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia | Completed | American Rhinologic Society | Phase 1/Phase 2 | 2011-02-01 | The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SOTRADECOL
Condition Name
Clinical Trial Locations for SOTRADECOL
Trials by Country
Clinical Trial Progress for SOTRADECOL
Clinical Trial Phase
Clinical Trial Sponsors for SOTRADECOL
Sponsor Name